Resources from the same session
1428 - Characterization of the immune tumor microenvironment (TME) to inform personalized medicine with immuno-oncology (IO) combinations
Presenter: Jason Luke
Session: Poster Discussion session - Immunotherapy of cancer 2
Resources:
Abstract
2016 - Discrepancy of tumor neoantigen burden between primary lesions and matched metastases in lung cancer
Presenter: Tao Jiang
Session: Poster Discussion session - Immunotherapy of cancer 2
Resources:
Abstract
2690 - Identification of Adenosine Pathway Genes Associated with Response to Therapy with the Adenosine Receptor Antagonist CPI-444
Presenter: Stephen Willingham
Session: Poster Discussion session - Immunotherapy of cancer 2
Resources:
Abstract
4471 - First in Human Study with GSK3359609 [GSK609], Inducible T cell Co-stimulator (ICOS) Receptor Agonist in Patients [Pts] with Advanced, Solid Tumors: Preliminary Results from INDUCE-1
Presenter: Aaron Hansen
Session: Poster Discussion session - Immunotherapy of cancer 2
Resources:
Abstract
1748 - Novel Small-Molecule ROR_ Agonist Immuno-oncology Agent LYC-55716: Safety and Efficacy in a Phase 2A Open-Label, Multicenter Trial
Presenter: Judy Wang
Session: Poster Discussion session - Immunotherapy of cancer 2
Resources:
Abstract
1456 - Phase I Study of KN035, a novel fusion Anti-PD-L1 Antibody administered subcutaneously in Patients with Advanced Solid Tumors in the USA
Presenter: Kyri Papadopoulos
Session: Poster Discussion session - Immunotherapy of cancer 2
Resources:
Abstract
3757 - Association between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1
Presenter: Maria Kfoury
Session: Poster Discussion session - Immunotherapy of cancer 2
Resources:
Abstract
2558 - Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma: data from a French multicentric cohort
Presenter: Charlotte Domblides
Session: Poster Discussion session - Immunotherapy of cancer 2
Resources:
Abstract
Poster Discussion session - Immunotherapy of cancer 2 - Invited Discussant 1138PD, 1139PD and 1140PD
Presenter: Aurélien Marabelle
Session: Poster Discussion session - Immunotherapy of cancer 2
Resources:
Slides
Webcast
Poster Discussion session - Immunotherapy of cancer 2 - Invited Discussant 1041PD and 1042PD
Presenter: Inge-Marie Svane
Session: Poster Discussion session - Immunotherapy of cancer 2
Resources:
Slides
Webcast